Mixed-species malaria infections in humans
M Mayxay, S Pukrittayakamee, PN Newton… - Trends in …, 2004 - cell.com
Mixed-species malaria infections are often not recognized or underestimated. In Asia,
surveys usually report that< 2% of infections are mixed, whereas therapeutic studies in vivax …
surveys usually report that< 2% of infections are mixed, whereas therapeutic studies in vivax …
[PDF][PDF] Design and interpretation of vaccine field studies
ME Halloran, IM Longini Jr, CJ Struchiner - Epidemiologic reviews, 1999 - Citeseer
Design and Interpretation of Vaccine Field Studies Page 1 Epidemiological Reviews
Copyright © 1999 by The Johns Hopkins University School of Hygiene and Public Health All …
Copyright © 1999 by The Johns Hopkins University School of Hygiene and Public Health All …
Statistics for Biology and Health
M Gail, K Krickeberg, J Samet, A Tsiatis, W Wong - 2010 - Springer
Immunization is one of the great advances in public health. Figure 0.1 shows a camel with a
solar-powered refrigerator on his back carrying vaccines across a hot desert to the far …
solar-powered refrigerator on his back carrying vaccines across a hot desert to the far …
Vaccines for preventing malaria (SPf66)
PM Graves, H Gelband… - Cochrane Database …, 1996 - cochranelibrary.com
Background A malaria vaccine is badly needed. SPf66 was one of the earliest vaccines
developed. It is a synthetic peptide vaccine containing antigens from the blood stages of …
developed. It is a synthetic peptide vaccine containing antigens from the blood stages of …
Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea
A Phase I safety and immunogenicity study with a three-component blood-stage malaria
vaccine was conducted in adult male subjects living in an endemic area of Papua New …
vaccine was conducted in adult male subjects living in an endemic area of Papua New …
Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant …
SPf66 is a synthetic malaria peptide vaccine, which has been widely tested in combination
with aluminium hydroxide (alum) as the adjuvant. Since this formulation is weakly …
with aluminium hydroxide (alum) as the adjuvant. Since this formulation is weakly …
Malaria vaccine: candidate antigens, mechanisms, constraints and prospects
LJM Carvalho, CT Daniel‐Ribeiro… - Scandinavian journal of …, 2002 - Wiley Online Library
More than 30 years after the first report of successful vaccination against malaria using
radiation‐attenuated sporozoites, an effective malaria vaccine is not yet available. However …
radiation‐attenuated sporozoites, an effective malaria vaccine is not yet available. However …
Prevalence of congenital malaria in Ile-Ife, Nigeria
PO Obiajunwa, JA Owa… - Journal of Tropical …, 2005 - academic.oup.com
The study was designed to determine the prevalence of congenital malaria, cord blood and
placental malaria parasitaemia and the prevalence of clinical manifestations of congenital …
placental malaria parasitaemia and the prevalence of clinical manifestations of congenital …
Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate
R Thomson-Luque, TC Stabler, K Fürle… - Expert Review of …, 2024 - Taylor & Francis
Introduction Malaria represents a public health challenge in tropical and subtropical regions,
and currently deployed control strategies are likely insufficient to drive elimination of malaria …
and currently deployed control strategies are likely insufficient to drive elimination of malaria …
The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents
Development of an effective HIV-1 vaccine would greatly advance prospects for control of
the AIDS epidemic. To date, development of vaccine candidates has been of limited …
the AIDS epidemic. To date, development of vaccine candidates has been of limited …